Diabetes

In this interview, Lisa Jones MA, RDN, LND, FAND talks to Rachel Stahl Salzman, MS, RDN, CDN, CDCES, about possible misconceptions about digital health devices in the management of patients with diabetes,...

In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.

Results of a new study show that major weight loss has the same impact on diabetes remission whether through weight loss surgery or diet. In this Q&A, lead researcher Samuel Klein, MD, answers our...

Consultant360 spoke with lead author Greg Kinney, PhD, about his study, which found that cannabis use may be associated with an increased risk for diabetic ketoacidosis in patients with type 1 diabetes. ...

We spoke with Gilad Twig, MD, PhD, whose recent study indicates that resolved acute pancreatitis during childhood may be a risk factor for incident diabetes in adulthood.

Christianne Roumie, MD, MPH, answers our questions about her new study, which compared the incidence of diabetes and impaired fasting glucose among participants from the SPRINT Randomized Trial.

In a recent study, researchers assessed the relationship and resulting impact of exercise capacity on all-cause mortality risk among people with type 2 diabetes. Lead study author Yun-Ju Lai, MD, discussed...

Aveni Haynes, PhD, discusses findings from her new study, which suggested that improvements in HbA1c and decreases in severe hypoglycemia rates have occurred concurrently over the past 2 decades in the...

Endocrinology Consultant spoke with Derek LeRoith, MD, PhD, member of the task force that developed the Endocrine Society’s 2019 clinical practice guideline for the treatment of diabetes in older adults. ...